The downregulation of thioredoxin accelerated Neuro2a cell apoptosis induced by advanced glycation end product via activating several pathways

作者: Xiang Ren , Haiying Ma , Yuanyuan Qiu , Bo Liu , Hui Qi

DOI: 10.1016/J.NEUINT.2015.06.009

关键词:

摘要: Abstract Thioredoxin (Trx), a 12 kDa protein, has different functions in cellular environments, playing important anti-oxidative and anti-apoptotic roles regulating the expression of transcription factors. Advanced glycation end products (AGEs) are heterogeneous group irreversible adducts from glucose–protein condensation reactions considered crucial to development diabetic nephropathy, retinopathy, neurodegeneration atherosclerosis. The aim this study was use Trx inhibitor investigate effects mechanism down-regulation on AGE-induced Neuro2a cell apoptosis. cells were cultured vitro treated with conditions. apoptosis proliferation detected using flow cytometry, DNA-Ladder CCK8 assays. Rho 123 used detect mitochondrial membrane potential. ROS generation caspase3 activity DCFH-DA probe micro-plate reader. Western blotting real-time PCR proteins genes. We found that thioredoxin could accelerate cells. A possible underlying is stimulated up-regulation ASK1, p-JNK, PTEN, Txnip, as well p-AKT, ultimately increasing levels activity.

参考文章(36)
Torvard C. Laurent, E. Colleen Moore, Peter Reichard, ENZYMATIC SYNTHESIS OF DEOXYRIBONUCLEOTIDES. IV. ISOLATION AND CHARACTERIZATION OF THIOREDOXIN, THE HYDROGEN DONOR FROM ESCHERICHIA COLI B. Journal of Biological Chemistry. ,vol. 239, pp. 3436- 3444 ,(1964) , 10.1016/S0021-9258(18)97742-2
Kumuda C. Das, Yvette Lewis-Molock, Carl W. White, Elevation of manganese superoxide dismutase gene expression by thioredoxin. American Journal of Respiratory Cell and Molecular Biology. ,vol. 17, pp. 713- 726 ,(1997) , 10.1165/AJRCMB.17.6.2809
Irfan Rahman, Saibal K Biswas, Aruna Kode, Oxidant and antioxidant balance in the airways and airway diseases European Journal of Pharmacology. ,vol. 533, pp. 222- 239 ,(2006) , 10.1016/J.EJPHAR.2005.12.087
Chun-Hung Chen, Sz-Jie Chen, Chin-Chuan Su, Cheng-Chieh Yen, To-Jung Tseng, Tzyy-Rong Jinn, Feng-Cheng Tang, Kuo-Liang Chen, Yi-Chang Su, kuan-I Lee, Dong-Zong Hung, Chun-Fa Huang, Chloroacetic acid induced neuronal cells death through oxidative stress-mediated p38-MAPK activation pathway regulated mitochondria-dependent apoptotic signals Toxicology. ,vol. 303, pp. 72- 82 ,(2013) , 10.1016/J.TOX.2012.10.008
Dunyaporn Trachootham, Jerome Alexandre, Peng Huang, Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nature Reviews Drug Discovery. ,vol. 8, pp. 579- 591 ,(2009) , 10.1038/NRD2803
Jinying Wei, Yonghong Shi, Yanjuan Hou, Yunzhuo Ren, Chunyang Du, Lianshan Zhang, Ying Li, Huijun Duan, Knockdown of thioredoxin-interacting protein ameliorates high glucose-induced epithelial to mesenchymal transition in renal tubular epithelial cells. Cellular Signalling. ,vol. 25, pp. 2788- 2796 ,(2013) , 10.1016/J.CELLSIG.2013.09.009
Mani Alikhani, Zoubin Alikhani, Coy Boyd, Christine M. MacLellan, Markos Raptis, Rongkun Liu, Nicole Pischon, Philip C. Trackman, Louis Gerstenfeld, Dana T. Graves, Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways. Bone. ,vol. 40, pp. 345- 353 ,(2007) , 10.1016/J.BONE.2006.09.011
Josephine V Glenn, Alan W Stitt, None, The role of advanced glycation end products in retinal ageing and disease Biochimica et Biophysica Acta. ,vol. 1790, pp. 1109- 1116 ,(2009) , 10.1016/J.BBAGEN.2009.04.016
Gu Jing, Clara Westwell-Roper, Junqin Chen, Guanlan Xu, C. Bruce Verchere, Anath Shalev, Thioredoxin-interacting Protein Promotes Islet Amyloid Polypeptide Expression through miR-124a and FoxA2 Journal of Biological Chemistry. ,vol. 289, pp. 11807- 11815 ,(2014) , 10.1074/JBC.M113.525022
Dler Faieeq Darweesh Mahmood, Amna Abderrazak, Khadija El Hadri, Thomas Simmet, Mustapha Rouis, The thioredoxin system as a therapeutic target in human health and disease Antioxidants & Redox Signaling. ,vol. 19, pp. 1266- 1303 ,(2013) , 10.1089/ARS.2012.4757